
AI as an accelerator for data-centric, process-centric, and human-centric clinical research.
Head, Pharma R&D Transformation, TCS Life Sciences, and Head, European Forum for Good Clinical Practices (EFGCP) eConsent initiative
AI as an accelerator for data-centric, process-centric, and human-centric clinical research.
Harmonization and value insights are fundamental to bring eConsent to the place it deserves.
Understanding differences in studies, sites, and patients are key to making eConsent successful.
As many countries slowly progress with the “New Normal,” researchers and healthcare providers are assessing digital/virtual approaches that could reinstate clinical trials.
A new SaaS platform for clinical trials, soon available to all pharma companies, aims to automate clinical supply, improve patient compliance and enable better medication adherence.
Janssen releases key findings from its pilot study evaluating the use of electronic informed consent technology in clinical trials.
Published: May 12th 2023 | Updated:
Published: August 1st 2016 | Updated:
Published: December 2nd 2016 | Updated:
Published: September 11th 2020 | Updated: